$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

항암제와 한약재의 병용투여 시 암세포 증식억제 효과에 대한 국내 실험연구 문헌고찰
A Review on Experimental Research about Anticancer Drug Combined Treatment with Herbal Medicine for Killing or Inhibiting Proliferation of Cancer cells in Korea. 원문보기

大韓韓醫學方劑學會誌 = Herbal formula science, v.25 no.3, 2017년, pp.391 - 412  

이지은 (부산대학교 한의학전문대학원 한의학과) ,  최진용 (부산대학교 한의학전문대학원 한의학과) ,  한창우 (부산대학교 한의학전문대학원 한의학과) ,  최준용 (부산대학교 한의학전문대학원 한의학과) ,  박성하 (부산대학교 한의학전문대학원 한의학과) ,  김소연 (부산대학교 한의학전문대학원 한의학과)

Abstract AI-Helper 아이콘AI-Helper

Objective : In this study, we searched the experimental research about combined treatment of anticancer drug and herbal medicine for killing or inhibiting proliferation of Cancer cells searched in OASIS and KISS. This study aimed to analyze the experimental research paper about anticancer drug combi...

주제어

질의응답

핵심어 질문 논문에서 추출한 답변
항암화학 요법의 경우 일반적으로 치료 횟수가 증가할수록 부작용은 증가하는가, 감소하는가? 서양의학에서의 암 치료법은 외과처치, 방사선요법, 화학요법, 호르몬요법, 면역요법 등이 사용되고 있지만 그에 수반되는 부작용과 한계점으로 보다 효과적이고 부작용이 적은 치료방법이 요구된다. 특히 항암화학 요법의 경우 일반적으로 치료 횟수가 증가할수록 부작용이 증가하는 경향이 있기 때문에 항암치료의 효과보다 부작용이 더 크게 나타난다면 의료진은 항암제의 투여 용량을 조정하거나 약물을 변경 혹은 중단 하는 등의 조치를 취하게 된다. 이러한 문제점을 해결하고 궁극적으로 항암효과를 높이기 위해 새로운 항암제 개발이나 기존에 사용하던 항암제의 병용투여에 대한 연구가 지속적으로 이루어지고 있다.
한의학에서 사용하는 항암 치료용 한약들이 효과가 있을지라도 서양의학의 항암 치료시 금지되는 이유는 무엇인가? 그러나 항암제와 한약 각각의 약물이 효과적이라고 해도 약물상호작용으로 인해 오히려 항암제의 효과를 저해하거나 부작용을 유발할 가능성이 있기 때문에 항암 치료 중 한약 복용을 금지시키는 경우가 대부분 이다. 설문연구에 따르면 협진이 이루어지고 있는 2 개소 한방병원에서 암환자의 한약 병용투여율은 각각 38.
서양의학에서의 암 치료법은 무엇이 있는가? 서양의학에서의 암 치료법은 외과처치, 방사선요법, 화학요법, 호르몬요법, 면역요법 등이 사용되고 있지만 그에 수반되는 부작용과 한계점으로 보다 효과적이고 부작용이 적은 치료방법이 요구된다. 특히 항암화학 요법의 경우 일반적으로 치료 횟수가 증가할수록 부작용이 증가하는 경향이 있기 때문에 항암치료의 효과보다 부작용이 더 크게 나타난다면 의료진은 항암제의 투여 용량을 조정하거나 약물을 변경 혹은 중단 하는 등의 조치를 취하게 된다.
질의응답 정보가 도움이 되었나요?

참고문헌 (62)

  1. National Cancer Information Center. Cancer Statistics. 2014: http://www.cancer.go.kr/mbs/cancer/subview.jsp?idcancer_040101000000 

  2. National Cancer Information Center. Major Cancer Death Rate. 2014: http://www.cancer.go.kr/mbs/cancer/subview.jsp?idcancer_040201000000 

  3. National Cancer Information Center. 10 years Survival Rate. http://www.cancer.go.kr/mbs/cancer/subview.jsp?idcancer_040305000000 

  4. National Cancer Information Center. Cure Principle.http://www.cancer.go.kr/mbs/cancer/subview.jsp?idcancer_020401020000 

  5. National Cancer Information Center. Anti-cancer Chemotherapy. http://www.cancer.go.kr/mbs/cancer/subview.jsp?idcancer_020403020000 

  6. Koreanoncology Textbook Publish Committee. Integrative Oncology of Korean Medicine. 1st ed. Kunja Publisher. 2013:17-18. 

  7. Kim CB, Yoo JS, Park JK, Koh KW, Choi SY. Combined Treatment of Oriental Herbal Medicine and Prescribed Drugs among Cancer Patients. The Journal of Korean Oriental Medicine. 2007;28(2):205-212. 

  8. Eun JS, Song WY. The Combined Effects of n-BuOH Fraction of Ulmi Cortex and Anticancer Drugs on Cancer Cell Lines. The Korean Journal of Pharmacognosy. 1994;25(2): 144-152. 

  9. Jeong HW, Choi JH, Jin CS. Effects of Flos Lonicerae and Herba Houtluynrae on Human Cancer Cells. The Korean Journal of Oriental Medical Pathology. 1996;10(1):126-132. 

  10. Jeong HW, Jeon BH. Cytotoxic Effects of Dictamni Cortex Radicis and Manitis Squama on Human Cancer Cells. The Korean Journal of Oriental Medical Pathology 1997;11(1):58-64. 

  11. Eun JS, Kim DK, Song JM. The Combined Effect of Moschus and Anti-tumor drug mitomycin C. The Korean Journal of Oriental Physiology & Pathology. 2003;17(6):1404-1408. 

  12. Kim JY, Jo OH, Choe CM, Cho HB. Rhizoma Rehmanniae induced Apoptosis in Human Cervical Carcinoma HeLa cells. The Journal of Oriental Obstetrics & Gynecology. 2006;19(1): 069-080. 

  13. Cho HJ. Synergistic Effect of cisplatin and Berberine on Inhibition of Cell Growth and Induction of Apoptosis involving Oxidative Stress in HeLa cells. The korean Journal Of Oriental Physiology & Pathology. 2007;21(4): 992-997. 

  14. Nam JY, Sung JS, Jun HI, Lee JW, Kwon SK, Kim DI. Increasing Effects of Apoptosis When Co-treated Scutellaria barbata D.Don. with Anti-cancer Drugs. The Journal of Oriental Obstetrics & Gynecology. 2009;22(1):125-139. 

  15. Lee HW, Song HJ, Kim SH. experimental Effects of Bangdoktang on the anti-cancer and Immuno-action. The Korean Journal of Oriental Medicine. 1994;15(1):263-281. 

  16. Cho YD, Jin CS, Jeong JH, Reu DR. The Combined Effect of Banhyun-hwan and Anticancer Drug in Human Cervical Carcinoma HeLa cells. The Journal of Oriental Gynecology. 1995;8(1): 49-62. 

  17. Song HJ, Kim JW, Kim SH. The Anti-tumor Effect of Herba Artemisiae Capillaris in Liver cancer cells and S-180. The Journal of Oriental Medical Pathology. 1995;10: 129-162. 

  18. Kim DH, Kim SH. The Anti-tumor activity of Taraxaci Herba in Liver cancer cells and The Combined Effect of Taraxaci Herba and Anti-cancer drug. The Korean Journal of Oriental Medicine. 1995;16(2):386-413. 

  19. Son GH, Kim SH. Antitumor Activity of Bupleuri Radix and Artemisiae capillaris Herba and Synergistic Effect with Anticancer Drugs. The Korean Journal of Oriental Medicine. 1995;16(2): 414-432. 

  20. Baek EK, Moon G. Won JH, Kim DU, Baek DG, Yoon JC, et al. Anticancer Effect of Combination with Paljinhangahm-dan and adriamycin on HepG2 Human Malignant Hepatoma Cell Line. The Korean Journal of Oriental Physiology & Pathology. 2003;17(5):1243-1250. 

  21. Kim SJ, Song BG, Lee GU, Won JH, Moon G, Moon SJ, et al. experimental Studies on Antitumor Effects of Paljintanghabhwajuckhwan. The Korean Journal Oriental Internal Medicine. 2000;21(1):65-73. 

  22. Lee BG, Moon G, Moon SJ, Won JH, Cho JY, Park SG, et al. Study on Synergistic Antitumor Effect of Combination with adriamycin and Palginhonhapwhajucwhan. The Korean Journal of Internal Medicine. 2000;21(3):443-452. 

  23. Jeon BH, Jeong WY. The Cytotoxicity of Methanol extract of Radix Codonopsitis and mitomycin C. The Journal of Traditional Korean Medicine. 1997;7(2):5-10. 

  24. Nam WY, Jeon BH. Effects of Ethanol extract of Radix Salviaemetiorrhizae on Anti-tumor Chemotherapeutic Cytotoxicity such as mitomycin C. The Korean Journal of Oriental Medical Pathology. 1997;11(2):113-117. 

  25. Jeon BH. Effects of Methanol extract of Radix Astragali on Anti-tumor Chemotherapeutic Cytotoxicity. The Korean Journal of Oriental Medical Pathology. 1998;12(1):55-59. 

  26. Jeon SH, Jeon BH, Won TH, Moon G. Moon SJ. Effects of Jukyeopseokgo-tanggagambang on Anti-tumor Chemotherapeutic Cytotoxicity and Lysosomal Enzymes of Tumor cell. The Journal of Korean Oriental Oncology. 1997;3(1):149-167. 

  27. Lee DJ, Moon SJ. Effects of Sipjeondaebotanggamibang on Anti-tumor Chemotherapeutic Cytotoxicity and Lysosomal Enzymes of Tumor cell. The Journal of Traditional Korean Medicine. 1997;7(2):116-123. 

  28. Moon G, Kim BJ, Jeon BH, Won TH, Moon SJ. experimental Studies on the Anti-tumor Effects of Bujeonghangam-tang. The Journal of Korean Oriental Medical Pathology. 1997;11(2):16-26. 

  29. Kim GT, Jeon BH. Effects of Gamihagochosan on Anti-tumor Cytotoxicity and Tumor cell. The Journal of Korean Internal Medicine. 1997;18(1):175-190. 

  30. Cho HJ, Won TH, Moon G, Moon SJ, Jeon BH. Effects of Soyosangamibang on antitumor chemotherapy and lysosomal enzymes of tumor cell. The Korean Journal of Oriental Medicine. 1997;18(2):119-136. 

  31. Jeong DH, Choi JH, Kim JH, Jeong HW. experimental Effects of Taklihwangkitang on the anti-cancer and Immuno-action. The Journal of Oriental Medical Surgery, Ophthalmology & Otolaryngology. 2002;15(2):118-131. 

  32. Shim SH, Kim JH, Choi JH, Jeong HW. Influences on the anticancer and inhibitive effects of the secondary effects by Anticarcinogen of Shibyukmiyoukieum. The Journal of Oriental Medical Surgery, Ophthalmology & Otolaryngology. 2002;15(2):302-314. 

  33. Chang WL, Kim JH, Choi JH, Park SY. experimental Effects of Sunjeonhwadoktang on the Proliferation of Cancer Cells and Immunocytes - Focusing around combined Effects of Anticarcinogen - The Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology. 2005;18(1):104-115. 

  34. Ahn MS, Kim SG, Eun JS, Lim JP, Yum JY, Suh ES, et al. Studies on the combined Effect of Several Combined Preparation of Crude Drugs and mitomycin C(I). The Korean Journal of Pharmacognosy. 1992;22(3):158-170. 

  35. Jeon JH, Ryu KW, Kim JS, Yoon SH, Ryu BH. Combined application of Astragali Radix and chlorambucil on anticancerous effect and host safety in Lukemia Cell(P388D1 cell) and its Bearing mice. The Korean Journal of Oriental Internal Medicine. 2005;26(2):291-301. 

  36. Kim HS, Kim SH. Effects of Wekyungtang and Kami-Wekyungtang on Pulmonary Tumor Cells and the Changes of Tissues. The Journal of Oriental Medical Pathology. 1995;10:217-245. 

  37. Seong HJ, Yoon YS. experimental Studies on the Kidney Cytotoxicity of Mouse by cisplatin and Liver Function of Sophora flavescens Aiton Effects. The Journal of Oriental Medical Surgery, Ophthalmology & Otolaryngology. 2001;14(1): 167-172. 

  38. Kim JC, Lim SC, Jung TY, Jung CS, Han SW. Inhibitory Effects of Sophora flavescens Aiton on the Pancreatic & Cardiac Side Effects of Chemotherapy by cisplatin. The Korean J. Oriental Physiology & Pathology. 2005;19(4): 945-949. 

  39. Kim JC, Lee KM, Byun BH, Lim SC, Jung TY, Seo JC, et al. Inhibitory Effects of Sophora flavescens Aiton on the Hepatic & Renal Side Effects of Chemotherapy by cisplatin. The Korean Journal of Meridian & Acupoint. 2005;22(3):165-174. 

  40. Kim TW, Son CK, Cho CK. Studies on the effects of Sojeokbaekchoolsan on the bleomycin induced pulmonary fibrosis and the anti-tumor activity. The Journal of Korean Oriental Oncology. 1999;5(1):77-101. 

  41. Park KS, Park JH, Kim DH, Kim SH. Effects of Wekyungtang and KamiWekyungtang on Cytotoxicity of A549 cells and Antitumor Effect of S-180. The Journal of Oriental Medical Pathology. 1995;10:217-245. 

  42. Ko YC, Lee SE, Park JY. Study on Anticancer Mechanism of Gilkyeungtang in Lung Cancer Cells. The Journal of The Korea Institute Of Oriental Medical Informatics. 2003;9(2):94-114. 

  43. Lee YH, Kim BS, Oh JH, Lim HY, Kim DW, Choi BH, et al. The Anti-tumor Effect of Bojungikkeehapdaechilkitang with doxorubicin in 3LL. The Korean Journal of Oriental Medical Prescription. 2004;12(1):131-148. 

  44. Hur JC, Won JH, Kim DW, Han SH, Moon G. Antitumor Effect of the Cotreatment of Gagamsibjeondaebotang and $As_2O_3$ in Human Lung Cancer Cell Line H-460. The Korean Journal of Oriental Physiology & Pathology. 2004;18(4):1089-1097. 

  45. Lee BH, Won JH, Kim DW, Lee JD, Moon G. Antitumor Effect of Gagamjengactang and $As_2O_3$ in Human Lung Cancer Cell Line H-157. The Korean Journal of Oriental Medicine. 2004;25(3):191-202. 

  46. Shin MK, Kim BS, Oh JH, Lim HY, Kim DW, Choi BH, et al. The Anti-tumor Effect of Soonkiwhajungtang with doxorubicin in Colon-26. The Korean Journal of Oriental Medical Prescription. 2004;12(2):119-137. 

  47. Lee YH, Byun JS. The Anti-tumor Effect of Bojungikkeehapdaechilkitang with doxorubicin in Colon-26. The Journal of Korean Oriental Medicine. 2004;25(2):9-21. 

  48. Ahn HM, Han SY, Kim JH, Rho TW, Chong MS, Kim YK. Effects of Cheongpyesagan-tang and YKK012 on in vitro and in vivo Colon Cancer Cell Growth with and without CPT-11. The Korean Journal of Medicine Herbology. 2015;30(1): 33-42. 

  49. Kim SM, Yun JM, Lee KS, Lee YU, Na HS, Yoo BS, et al. Study on Apoptosis Inducement of Human Glioblastoma Cells by SaengMaecSan. The Korean Journal of Oriental Internal Medicine. 2003;24(4):870-881. 

  50. Lee YH, Kim BS, Oh JH, Lim HY, Kim DW, Choi BH, et al. The Anti-tumor Effect of Bojungikkeehapdaechilkitang with doxorubicin in MKN-45. The Korean Journal of Oriental Internal Medicine. 2004;25(1):92-105. 

  51. Shin MK, Byun JS. The Anti-tumor Effect of Soonkiwhajungtang with doxorubicin in MKN-45 Conclusion. The Korean Journal of Oriental Medicine. 2004;25(2):98-109. 

  52. Shin HS, Lee SW, Lee MG, Yun JM, Lee I, Sin SH, et al. Mechanisms of Apoptosis by Combination with Jeongjihwan and cisplatin in Human Glioblastoma Cells. The Korean Journal of Oriental Medicine. 2005;26(2):1-12. 

  53. Choi SH, Oh MS, Song TW, Nam GY. Immunopotentiating Effects and Antitumor activities of Sipjundaebo-tang. The Journal of Daejeon University College of Korean Medicine. 2002;11(1):257-238. 

  54. Kang YI, Kim TL, Park JO, Kim SH, Park JD, Kim DH. Compilation of 104 Experimental Theses on the Antitumor and Immunoactivating Therapies of Oriental Medicine. The Korean Journal Oriental Physiology & Pathology. 2003;17(1):1-24. 

  55. Kim JH, Kim C, Kim SK, Jang HC, Han JM, Yea SJ, et al. Analysis of Studies on Combined Medication of the Oriental and the Western Medicines. Korean Journal Oriental Preventive Medical Society. 2009;13(3):1-18. 

  56. Donald Abrams, Andrew Weil, Integrative Oncology. 1st ed. E public. 2009:19 

  57. YANG YF1, GE JZ, WU Y, XU Y, LIANG BY, LUO L, et al. Cohort study on the effect of a combined treatment of traditional Chinese medicine and Western medicine on the relapse and metastasis of 222 patients with stage II and III colorectal cancer after radical operation. Chin J Integr Med. 2008;14(4):251-256. 

  58. Liao YH1,2, Lin CC3,4,5, Lai HC4,6, Chiang JH7,8,9, Lin JG1, Li TC. Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patients. Liver Int. 2015;35(12): 595-602. 

  59. Wing Lam, Zaoli Jiang, Fulan Guan, Xiu Huang, Rong Hu, Jing Wang, et al. PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment. Scientific Reports 2015;5:9384. 

  60. Muhammad Wasif Saif, Jia Li, Lynne Lamb, Kristin Kaley, Kyle Elligers, Zaoli Jiang, et al. First-in-human Phase II trial of the Botanical Formulation PHY906 with Capecitabine as Second-line Therapy in Patients with Advanced Pancreatic Cancer. Cancer Chemother Pharmacol. 2014;73(2):373-380. 

  61. Donald Abrams, Andrew Weil, Integrative Oncology. 1st ed. E public. 2009:276. 

  62. Kim BS, Kim JH, Kim KM, Choi JJ. Statistical Method for Testing Synergism among Several Compounds. The Korean Journal of Applied Statistics. 1993;6(2):383-391. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

FREE

Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로